本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

3.26
+0.06001.87%
成交量:218.23萬
成交額:703.98萬
市值:17.44億
市盈率:-3.19
高:3.27
開:3.20
低:3.18
收:3.20
52周最高:7.18
52周最低:2.77
股本:5.35億
流通股本:5.22億
量比:0.81
換手率:0.42%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
淨資產收益率:-56.58%
總資產收益率:-27.33%
市淨率:1.91
市盈率(LYR):-2.26

資料載入中...

2024/10/18

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/02

重要事件披露

Form 8-K - Current report
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities